Alana M Rojewski
Overview
Explore the profile of Alana M Rojewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wedel A, Walters K, Tomko R, Rojewski A, McClure E
Support Care Cancer
. 2025 Jan;
33(2):78.
PMID: 39775254
Purpose: Cancer survivors in a state with no legal access to cannabis may be hesitant to discuss their cannabis use with providers, particularly in light of legal consequences which disproportionately...
2.
Smith T, Crawford A, Ferreira A, Wahlquist A, Cummings K, Rojewski A, et al.
Nicotine Tob Res
. 2024 Sep;
27(3):553-557.
PMID: 39233579
Introduction: We conducted a pilot study to test the feasibility of a future randomized controlled trial comparing e-cigarettes to traditional pharmacotherapy among people who smoke daily, were motivated to quit,...
3.
Cummings K, Talbot V, Roberson A, Bliss A, Likins E, Brownstein N, et al.
BMC Health Serv Res
. 2024 Jun;
24(1):741.
PMID: 38886764
Objective: Describe the screening, referral, and treatment delivery associated with an opt-out tobacco treatment program (TTP) implemented in six hospitals varying in size, rurality and patient populations. Methods: Between March...
4.
Stang G, Tanner N, Hatch A, Godbolt J, Toll B, Rojewski A
JMIR Form Res
. 2024 Jun;
8:e53159.
PMID: 38865702
Background: Approximately 14 million individuals in the United States are eligible for lung cancer screening (LCS), but only 5.8% completed screening in 2021. Given the low uptake despite the potential...
5.
Cartmel B, Fucito L, Bold K, Neveu S, Li F, Rojewski A, et al.
J Thorac Oncol
. 2023 Nov;
19(4):643-649.
PMID: 37977486
Introduction: To determine whether personalized gain-framed messaging and biomarker feedback related to tobacco cessation or reduction decrease smoking behavior in patients undergoing or eligible for lung cancer screening. Methods: Between...
6.
Sanford B, Brownstein N, Baker N, Palmer A, Smith T, Rojewski A, et al.
JAMA Intern Med
. 2023 Nov;
184(1):106-108.
PMID: 37955869
No abstract available.
7.
Rojewski A, Palmer A, Baker N, Toll B
Nicotine Tob Res
. 2023 Jul;
26(1):31-38.
PMID: 37474127
Introduction: This study sought to compare medication efficacy in participants with medical comorbidities who smoke in the Evaluating Adverse Events in a Global Smoking Cessation Study (EAGLES) trial, a double-blind,...
8.
Price S, Palmer A, Fucito L, Graboyes E, Baker N, Rojewski A, et al.
Cancer
. 2023 May;
129(15):2385-2394.
PMID: 37211959
Background: Understanding the relationship between tobacco use and symptom burden may inform tobacco treatment interventions tailored to the needs of individuals with cancer. Methods: The study included 1409 adult cancer...
9.
Sanford B, Toll B, Fucito L, Baker N, Krishnan-Sarin S, Carpenter M, et al.
Nicotine Tob Res
. 2023 May;
25(9):1614-1618.
PMID: 37156634
Introduction: Contingency management (CM) interventions deliver monetary reinforcers contingent upon biochemically verified abstinence from smoking. CM has been found to be effective, however, individual participant, analyses are warranted to further...
10.
Sanford B, Rojewski A, Palmer A, Baker N, Carpenter M, Smith T, et al.
Am J Prev Med
. 2023 Mar;
65(3):517-520.
PMID: 36878414
Introduction: Primary care visits present an opportune time to assess behaviors that contribute to patient health. Smoking, alcohol use, and illicit drugs are routinely documented in electronic health records, but...